GL1X · GenesisL1 explorer

MolNFT v1 · #27803 · protein

X-ray structure of lfa-1 I-domain bound to a 1,4-diazepane- 2,5-dione inhibitor at 1.8A resolution

1XUO · Integrin alpha-L: “X-ray structure of lfa-1 I-domain bound to a 1,4-diazepane- 2,5-dione inhibitor at 1.8A resolution”. X-ray diffraction, 2 ligands (LA1, MG), 3 pockets (best druggability 0.77). MolNFT v1 #27803 on GenesisL1: 3D…

PDB
1XUO
Type
protein
Length
356 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrin alpha-L
UniProt
P20701
Ligands
LA1, MG
Pockets
3 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegrin alpha-Lprotein18141% helix, 23% strandP20701
BIntegrin alpha-Lprotein17540% helix, 24% strandP20701

Ligands and binding sites

  • LA1 · (2R)-2-[3-isobutyl-2,5-dioxo-4-(quinolin-3-ylmethyl)-1,4-diazepan-1-yl]-N-methyl-3-(2-naphthyl)propanamide · ligand · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16510.770.8250LA1
21540.530.7916empty
3800.300.7320empty

Interfaces

1 interface between chains.

  • A–B · 471 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 1XUO · X-ray structure of LFA-1 I-domain bound to a 1,4-diazepane-2,5-dione inhibitor at 1.8A… · the same entry in another collection · chain A against A, TM-score 1.00
  • P20701 · AlphaFold monomer V2.0 prediction for integrin alpha-L (P20701) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.